Anti-interleukin 5 treatment in moderate to severe eosinophilic chronic obstructive pulmonary disease: a systematic review and meta-analysis

I. Tan (Manila, Philippines), R. Villalobos (Manila, Philippines), A. Jaen (Manila, Philippines), A. David-Wang (Manila, Philippines)

Source: International Congress 2019 – Advances in COPD pharmacology
Session: Advances in COPD pharmacology
Session type: Poster Discussion
Number: 2042
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. Tan (Manila, Philippines), R. Villalobos (Manila, Philippines), A. Jaen (Manila, Philippines), A. David-Wang (Manila, Philippines). Anti-interleukin 5 treatment in moderate to severe eosinophilic chronic obstructive pulmonary disease: a systematic review and meta-analysis. 2042

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Misdiagnosed COPD: systematic review and meta-analysis
Source: Annual Congress 2007 - Delivering respiratory care: the challenges for primary care
Year: 2007



Global burden of COPD: systematic review and meta-analysis
Source: Eur Respir J 2006; 28: 523-532
Year: 2006



Arm training in patients with chronic obstructive pulmonary disease: a systematic review
Source: Annual Congress 2009 - Improving outcome through exercise training or physiotherapy interventions
Year: 2009


The effect of methlyxanthines as adjunct to corticosteroids among chronic obstructuve pulmonary disease patients in acute exacerbation: a systematic review and meta-analysis
Source: Virtual Congress 2020 – Pharmacological management of COPD
Year: 2020


Early supported discharge/hospital at home for exacerbation of chronic obstructive pulmonary disease, A review and meta-analysis
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016

Prevalence of undiagnosed COPD: systematic review and meta-analysis
Source: Annual Congress 2007 - Management of COPD: pushing forward the boundaries in primary care
Year: 2007




Efficacy of erdosteine (E) in the treatment of exacerbated and stable chronic bronchitis or chronic obstructive pulmonary disease (CB/COPD): a meta-analysis of individual patient data
Source: Annual Congress 2009 - Drug effects in COPD
Year: 2009

The clinical characteristics of eosinophilic chronic obstructive pulmonary disease:A cohort study
Source: Virtual Congress 2020 – Investigations of COPD
Year: 2020

Acute exacerbations of chronic obstructive pulmonary disease: current recommendations review and quality of evidence analysis.
Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling
Year: 2020

The effect of long-term macrolides therapy for acute exacerbation of chronic obstructive pulmonary disease: A meta-analysis
Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management
Year: 2012

Tiotropium for the treatment of stable chronic obstructive pulmonary disease: A meta-analysis of clinically relevant outcomes
Source: Annual Congress 2010 - COPD: management
Year: 2010


Prevalence of metabolic syndrome among patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis
Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD
Year: 2015


Phenotype of patients with severe pulmonary hypertension secondary to chronic obstructive pulmonary disease: A multicentre study.
Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases
Year: 2020


²Hospital at home² versus inpatient care for patients with acute exacerbations of chronic obstructive pulmonary disease: cochrane systematic review and meta-analysis
Source: Eur Respir J 2003; 22: Suppl. 45, 445s
Year: 2003

Comparison of two physiotherapy treatments in patients with acute exacerbation of chronic obstructive pulmonary disease: a pilot study
Source: Virtual Congress 2021 – A multidisciplinary approach to pulmonary rehabilitation and management of chronic respiratory diseases
Year: 2021


Mild cognitive impairment in chronic obstructive pulmonary disease and chronic heart failure: A systematic review and meta-analysis
Source: International Congress 2016 – Managing multimorbidity and lifestyle change in primary care
Year: 2016

Role and distribution of infectious agents in exacerbations of moderate, severe and very severe forms of chronic obstructive lung disease: a prospective trial
Source: Eur Respir J 2006; 28: Suppl. 50, 735s
Year: 2006

Oral theophylline benefits stable 'irreversible' chronic obstructive pulmonary disease: a systematic review and meta-analysis
Source: Eur Respir J 2002; 20: Suppl. 38, 374s
Year: 2002

The safety of sputum induction in patients with exacerbation of severe and very severe COPD (chronic obstructive pulmonary disease)
Source: Annual Congress 2008 - Organisation of care and management of COPD
Year: 2008


The association between morning symptoms and physical activity in chronic obstructive pulmonary disease: A systematic review
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016